NewslettersImmune Regulation NewsKDM5A Inhibits Antitumor Immune Responses Through Downregulation of the Antigen-Presentation Pathway in Ovarian CancerBy Danielle Corrigan - June 24, 20220119Scientists demonstrated that a lysine 4 histone H3 demethylase (KDM5A) impaired epithelial ovarian cancer infiltration by immune cells and inhibited antitumor immune responses.[Cancer Immunology Research]Abstract